Abstract
Introduction: Kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) are the leading novel biomarkers used efficiently in acute kidney injury (AKI). The levels of these biomarkers increase especially in the early period of nephrotoxic and ischemic renal damage. In this study, we aimed to investigate the clinical importance of NGAL and KIM-1 biomarkers used in the effective evaluation of kidney functions in patients with acute unilateral obstructive stone disease (AUOSD) in the management of endoscopic surgery. Materials and Methods: We prospectively included patients who underwent endoscopic surgery due to AUOSD between January 2018 and December 2019. Urine KIM-1 and NGAL values of the patients were measured preoperative period, postoperative 4th h, and postoperative 7th day. The patients were evaluated according to the location and size of the stone, the degree of renal hydronephrosis, the duration of the operation, complications, and JJ stent placement. Results: The study enrolled 50 patients. Urinary KIM-1/Cr and urinary NGAL/Cr ratios were higher in postoperative 4th h than in others (p < 0.001). Also, we found that urinary KIM-1/Cr and urinary NGAL/Cr ratios with Grade 2 and higher hydronephrosis were statistically higher than Grade 0–1 hydronephrosis (p < 0.001 and p: 0.042, respectively). Additionally, a preoperative urinary KIM-1 value of 1.24 ng/mL had a sensitivity of 78% and a specificity of 63% to predict the presence of hydronephrosis. When urine KIM-1 and NGAL results were compared with surgery time, stone size and location, serum creatinine (sCr) value, and Post-Ureteroscopic Lesion Scale grade, the difference was not statistically significant. Postoperative 7th day NGAL/Cr and KIM-1/Cr ratios were statistically higher in those with JJ stents placed (p: 0.03 and p: 0.004, respectively). Conclusion: KIM-1 and NGAL can be used in our assessment of renal function in patients with AUOSD, even if sCr is normal. Also, these biomarkers can predict the presence of hydronephrosis. It can be helpful in determining the time of surgical treatment, as well as providing information in the follow-up of patients with JJ stents after treatment.
References
1.
Scales
CD
Jr, Smith
AC
, Hanley
JM
, Saigal
CS
; Urologic Diseases in America Project
. Prevalence of kidney stones in the United States
. Eur Urol
. 2012
;62
(1
):160
–5
. .2.
Misseri
R
, Rink
RC
, Meldrum
DR
, Meldrum
KK
. Inflammatory mediators and growth factors in obstructive renal injury
. J Surg Res
. 2004
;119
(2
):149
–59
. .3.
Devarajan
P
. Biomarkers for the early detection of acute kidney injury
. Curr Opin Pediatr
. 2011
;23
(2
):194
. .4.
Wasilewska
A
, Taranta-Janusz
K
, Dębek
W
, Zoch-Zwierz
W
, Kuroczycka-Saniutycz
E
. KIM-1 and NGAL: new markers of obstructive nephropathy
. Pediatr Nephrol
. 2011
;26
(4
):579
–86
. .5.
Yang
L
, Brooks
CR
, Xiao
S
, Sabbisetti
V
, Yeung
MY
, Hsiao
LL
, KIM-1-mediated phagocytosis reduces acute injury to the kidney
. J Clin Invest
. 2015
;125
(4
):1620
–36
. .6.
Perrin
T
, Descombes
E
, Magnin
JL
, Gachet
M
, Hemett
OM
, Hayoz
D
, Urinary neutrophil gelatinase-associated lipocalin (uNGAL) and contrast-induced acute kidney injury after coronary angiogram
. Swiss Med Wkly
. 2013
;143
(3536
):w13853
. .7.
Cruz
DN
, de Cal
M
, Garzotto
F
, Perazella
MA
, Lentini
P
, Corradi
V
, Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population
. Intensive Care Med
. 2010
;36
(3
):444
–51
. .8.
Mishra
J
, Dent
C
, Tarabishi
R
, Mitsnefes
MM
, Ma
Q
, Kelly
C
, Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
. The Lancet
. 2005
;365
(9466
):1231
–8
. .9.
Xue
W
, Xie
Y
, Wang
Q
, Xu
W
, Mou
S
, Ni
Z
. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient
. Nephrology
. 2014
;19
(4
):186
–94
. .10.
Dent
CL
, Ma
Q
, Dastrala
S
, Bennett
M
, Mitsnefes
MM
, Barasch
J
, Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study
. Critical care
. 2007
;11
(6
):1
–8
.11.
Han
WK
, Bailly
V
, Abichandani
R
, Thadhani
R
, Bonventre
JV
. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury
. Kidney Int
. 2002
;62
(1
):237
–44
. .12.
Koyner
JL
, Vaidya
VS
, Bennett
MR
, Ma
Q
, Worcester
E
, Akhter
SA
, Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury
. Clin J Am Soc Nephrol
. 2010
;5
(12
):2154
–65
. .13.
Onen
A
. Grading of hydronephrosis: an ongoing challenge
. Front Pediatr
. 2020 Aug
;8
:458
. 14.
Ordon
M
, Urbach
D
, Mamdani
M
, Saskin
R
, D'A Honey
RJ
, Pace
KT
. The surgical management of kidney stone disease: a population based time series analysis
. J Urol
. 2014
;192
(5
):1450
–6
. .15.
Türk
C
, Petřík
A
, Sarica
K
, Seitz
C
, Skolarikos
A
, Straub
M
, EAU guidelines on diagnosis and conservative management of urolithiasis
. Eur Urol
. 2016
;69
(3
):468
–74
. .16.
Assimos
D
, Krambeck
A
, Miller
NL
, Monga
M
, Murad
MH
, Nelson
CP
, Surgical management of stones: American urological association/endourological society guideline, PART I
. J Urol
. 2016
;196
(4
):1153
–60
. .17.
Moody
TE
, Vaughn
ED
Jr, Gillenwater
JY
. Relationship between renal blood flow and ureteral pressure during 18 hours of total unilateral uretheral occlusion. Implications for changing sites of increased renal resistance
. Invest Urol
. 1975
;13
(3
):246
–51
.18.
Holmlund
D
. The pathophysiology of ureteral colic
. Scand J Urol Nephrol Suppl
. 1983
;75
:25
.19.
Kelleher
JP
, Wakefield
AJ
, Gordon
I
, Ransley
PG
. Renal injury in complete ureteric obstruction
. Urol Res
. 1991
;19
(4
):245
–8
. .20.
Thornhill
BA
, Forbes
MS
, Marcinko
ES
, Chevalier
RL
. Glomerulotubular disconnection in neonatal mice after relief of partial ureteral obstruction
. Kidney Int
. 2007
;72
(9
):1103
–12
. .21.
Waanders
F
, van Timmeren
MM
, Stegeman
CA
, Bakker
SJ
, van Goor
H
. Kidney injury molecule-1 in renal disease
. J Pathol
. 2010
;220
(1
):7
–16
. .22.
Paraboschi
I
, Mantica
G
, Dalton
NR
, Turner
C
, Garriboli
M
. Urinary biomarkers in pelvic-ureteric junction obstruction: a systematic review
. Transl Androl Urol
. 2020
;9
(2
):722
. .23.
Seibert
FS
, Sitz
M
, Passfall
J
, Haesner
M
, Laschinski
P
, Buhl
M
, Prognostic value of urinary calprotectin, NGAL and KIM-1 in chronic kidney disease
. Kidney Blood Press Res
. 2018
;43
(4
):1255
–62
. .24.
Olvera-Posada
D
, Dayarathna
T
, Dion
M
, Alenezi
H
, Sener
A
, Denstedt
JD
, KIM-1 is a potential urinary biomarker of obstruction: results from a prospective cohort study
. J Endourol
. 2017
;31
(2
):111
–8
. .25.
Taşdemir
M
, Fuçucuoğlu
D
, Küçük
SH
, Erol
M
, Yiğit
Ö
, Bilge
I
. Urinary biomarkers in the early detection and follow-up of tubular injury in childhood urolithiasis
. Clin Exp Nephrol
. 2018
;22
(1
):133
–41
. .26.
Qian
S
, Xia
W
, Wu
Y
, Cao
Q
, Ding
Y
, Huang
Y
, Urinary kidney injury molecule-1: a novel biomarker to monitor renal function in patients with unilateral ureteral obstruction
. Int Urol Nephrol
. 2020
;52
(11
):2065
–72
. .27.
Benli
E
, Ayyildiz
SN
, Cirrik
S
, Noyan
T
, Ayyildiz
A
, Cirakoglu
A
. Early term effect of ureterorenoscopy (URS) on the kidney: research measuring NGAL, KIM-1, FABP and CYS C levels in urine
. Int Braz J Urol
. 2017 Sep
;43
(5
):887
–95
. .28.
Dede
O
, Dağguli
M
, Utanğaç
M
, Yuksel
H
, Bodakci
MN
, Hatipoğlu
NK
, Urinary expression of acute kidney injury biomarkers in patients after RIRS: it is a prospective, controlled study
. Int J Clin Exp Med
. 2015
;8
(5
):8147
.29.
Hughes
SF
, Moyes
AJ
, Lamb
RM
, Ella-Tongwiis
P
, Bell
C
, Moussa
A
, The role of specific biomarkers, as predictors of post-operative complications following flexible ureterorenoscopy (FURS), for the treatment of kidney stones: a single-centre observational clinical pilot-study in 37 patients
. BMC urology
. 2020
;20
(1
):1
–10
.30.
Balasar
M
, Pişkin
MM
, Topcu
C
, Demir
LS
, Gürbilek
M
, Kandemir
A
, Urinary kidney injury molecule-1 levels in renal stone patients
. World J Urol
. 2016
;34
(9
):1311
–6
. .31.
Jung
HU
, Frimodt-Møller
PC
, Osther
PJ
, Mortensen
J
. Pharmacological effect on pyeloureteric dynamics with a clinical perspective: a review of the literature
. Urol Res
. 2006
;34
(6
):341
–50
. .32.
Fung
LC
, Atala
A
. Constant elevation in renal pelvic pressure induces an increase in urinary N-acetyl-beta-d-glucosaminidase in a nonobstructive porcine model
. J Urol
. 1998
;159
(1
):212
–6
. .33.
Caballero-Romeu
JP
, Galán-Llopis
JA
, Soria
F
, Morcillo-Martín
E
, Caballero-Pérez
P
, Garcia
A
, Micro-ureteroscopy versus ureteroscopy: effects of miniaturization on renal vascularization and intrapelvic pressure
. World J Urol
. 2018
;36
(5
):811
–7
. .34.
Shao
Y
, Shen
Z-J
, Zhu
Y-Y
, Sun
X-W
, Lu
J
, Xia
S-J
. Fluid-electrolyte and renal pelvic pressure changes during ureteroscopic lithotripsy
. Minim Invasive Ther Allied Technol
. 2012
;21
(4
):302
–6
. .35.
Cai
Y
, Li
X
, Zhu
B
, Chen
R
, Ye
C
, Wang
Y
, A practical pressure measuring method for the upper urinary tract during ureteroscopy
. Clin Invest Med
. 2012
;35
(5
):E322
–6
. .36.
Izadi
A
, Yousefifard
M
, Nakhjavan-Shahraki
B
, Baikpour
M
, Mirzay Razaz
J
, Hosseini
M
. Diagnostic value of urinary neutrophil gelatinase-associated lipocalin (NGAL) in detection of pediatric acute kidney injury; a systematic review and meta-analysis
. Int J Pediatr
. 2016
;4
(11
):3875
–95
.37.
Qian
S
, Huang
Y
, Wang
N
, Ding
Y
, Qi
J
, Yu
Y
. Urinary neutrophil gelatinase-associated lipocalin as a biomarker to monitor renal function in patients with obstructive ureteral calculi
. World J Urol
. 2019
;37
(6
):1197
–204
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
